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Abstract: This paper reviews a number of biomedical engineering approaches to help aid
in the detection and treatment of tropical diseases such as dengue, malaria, cholera,
schistosomiasis, lymphatic filariasis, ebola, leprosy, leishmaniasis, and American
trypanosomiasis (Chagas). Many different forms of non-invasive approaches such as
ultrasound, echocardiography and electrocardiography, bioelectrical impedance, optical
detection, simplified and rapid serological tests such as lab-on-chip and micro-/nano-fluidic
platforms and medical support systems such as artificial intelligence clinical support
systems are discussed. The paper also reviewed the novel clinical diagnosis and
management systems using artificial intelligence and bioelectrical impedance techniques
for dengue clinical applications.
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1. Introduction
The original designation of certain diseases as being tropical can be dated back to the 1898
publication of Sir Patrick Mansonʼs Tropical Diseases: A Manual of the Diseases of Warm Climates [1].
Tropical diseases (TD) are diseases that are widespread in or unique to the tropical and subtropical
regions. TDs are prevalent in hot and humid climates. TDs are caused by pathogenic agents such as
bacteria, viruses, parasites or fungi and are most often transmitted through carriers or vectors such as
insects and nematodes. These insects may carry a parasite, bacterium or virus that is transmitted via
their bite which disperses the infectious agent by subcutaneous blood or saliva exchange in humans
and animals. Examples of tropical diseases include malaria, tetanus, hepatitis, American
trypanosomiasis (chagas), dengue, yellow fever, cholera, nipah virus, and many others. We will look at
some of these where biomedical engineering approaches have contributed to their diagnosis and treatment.
Rapid, efficient and inexpensive diagnosis of TDs is vital for the effective treatment and quality
management of diseases in tropical regions. Diagnosis of TDs consists of a wide range of methods
including serological testing of pathogenic markers such as protein, antigen, and antibody (using the
enzyme-linked immunosorbent assay (ELISA) technique and various test kits), x-rays and physical
examination, as well as performing bacteria and fungi culture techniques. These methods typically
require a sample of bodily fluid, such as blood, sputum, or urine and/or stool samples. However, the
management and diagnosis of TDs face several challenges such as prolonged turnaround time for
assessment of specimens, high cost, a controlled environment, highly trained personnel, and large
blood or bodily fluid samples. Associated measurements are often invasive, and in order to be useful,
diagnostic methods must be accurate, simple and affordable for the population for which they are
intended. They must also provide a result in time to institute effective treatment and patient isolation
when necessary. Current diagnostic methods for TDs are frequently faced with challenges such as
inconsistency in specificity and sensitivity, a long turnaround time to receive results, and high cost or
specialization (which requires either an advanced and expensive laboratory setup, or skilled
technicians and clinicians, or both).
Recent research and studies in the past decade have proposed and introduced various biomedical
engineering approaches that attempt to address the issues faced in the diagnosis of tropical diseases.
This review paper focuses on current biomedical engineering approaches for the more prominent
diseases of dengue, malaria, cholera, schistosomiasis, lymphatic filariasis, ebola, leprosy,
leishmaniasis, and American trypanosomiasis (chagas). Many of these approaches can be extended to
other diseases as well.
These diseases were chosen as examples due to their severity and endemic nature and the perceived
limitations of the current diagnostic methodology. In recent years outbreaks of dengue have been
escalating and spreading geographically throughout the world with high mortality rates when timely
treatment is not administered [2,3]. The number of infections of malaria and schistosomiasis is in the
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range of hundreds of millions, with the annual mortality rates in the range of hundreds of
thousands [4,5]. From 2009 to 2010, the number of cases and deaths due to cholera has increased by
about 50% [6], while sporadic outbreaks of ebola have been noted to be extremely deadly, killing the
patient within 2 days after acquiring the infection [7]. The disease of lymphatic filariasisis is wide
spread, infecting 120 million people and disfiguring 40 million worldwide [8], while leprosy has an
annual infection rate of 200,000 a year, and causes permanent damage to the skin, nerves, limbs and eyes
if untreated [9]. Around the world, millions of people are infected with leishmaniasis and American
trypanosomiasis (chagas), and millions more are at risk due to the endemic nature of these
diseases [10–12].
Although the diseases are different, many of the biomedical engineering approaches are common
for their diagnosis and treatment. Table 1 presents the relation between the diseases and biomedical
engineering approaches for their Diagnosis and Treatment. In the following sections we review
biomedical engineering approaches that are currently available for diagnosis and establishing
prognosis of the tropical diseases listed in Table 1. As seen in the table, a wider variety of biomedical
engineering approaches have been applied to diseases such as dengue and malaria than some of the
diseases on the right side of the table.
Table 1. Relation between the Tropical Diseases and their Diagnosis and Treatment via
Biomedical Engineering approaches.

Leishmaniasis

Chagas

Leprosy

X

Ebola

X

Lymphatic
Filariasis

Schistosomiasis

X

Cholera

Bioelectric Impedance Analysis
Bioelectric Properties
Biosensor
Clinical Decision Support Systems
Dielectrophoresis
Echocardiography
Electrocardiography
Image Processing
Imaging: Computed Tomography (CT) and
Magnetic Resonance Imaging (MRI)
Imaging: Ultrasonic
Laser Doppler Velocimetry
Microarray chip
Microfluidics and Lab-on-a-Chip
Paper-based Diagnostic
Plethysmography

Malaria

Biomedical Engineering Approach to
Diagnosis and Treatment

Dengue

Tropical Diseases

X

X

X
X
X
X
X
X
X

X
X
X
X
X

X
X
X

X

X

X

X

X

X

X
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2. Dengue
One of the most rapidly spreading mosquito-borne viral diseases in the world is dengue.
The incidence of dengue has increased in the last 50 years as a result of increasing geographic
expansion to new countries and to rural areas [2]. Annually, the World Health Organization (WHO)
estimates the occurrence of 50 million dengue infections occurring and approximately 2.5 billion
people facing threats of dengue since they live in dengue endemic areas [13].
According to the WHO 1997 guidebook of Dengue Haemorrhagic Fever: Diagnosis, Treatment,
Prevention and Control, 2nd ed. [13], some patients develop dengue fever (DF) in the early stage after
a person is infected with the dengue virus and recover after the fever subsides, while other patients
may progress on to develop dengue haemorrhagic fever (DHF).
Laboratory and clinical diagnosis are used to diagnose the dengue patient. The clinical diagnosis
and severity of DHF were graded from grades I to IV based on the WHO guidebook recommendation
in 1997 [13]. The WHO guidelines define Grade I as patients having a fever accompanied by
nonspecific constitutional symptoms with the only haemorrhagic manifestation being a petechial rash.
Grade II is defined as patients having a spontaneous bleeding from any site on their skin. Grades III
and IV are known as dengue shock syndrome (DSS). Grade III is where a patient has circulatory
failure manifested by rapid and weak pulse, narrowing of pulse pressure (20 mmHg or less) or
hypotension, with the presence of cold clammy skin and restlessness. Grade IV (DSS) is defined as
patients having profound shock [13].
With the WHO 1997 dengue severity classification guideline [13], many clinicians experienced
several difficulties especially in the critical cases such as the DHF patients which may experience
significant plasma leakage that may lead to haemorrhage and organ impairment. The decision to admit
those patients to the hospital in order to monitor their plasma leakage is a great challenge due to the
overlapping of present medical classification criteria for establishing the risk of dengue patients [14,15].
On the other hand, physicians cannot decide to admit all patients because this will have an impact on
the cost and quality of health care due to the high incidence of dengue in the tropics. Thus, to
overcome these difficulties and to assist clinicians in determining the severity of the infection and how
patients should be treated, the WHO has improved and introduced the new [2] guidebook which
defines the dengue patients’ classification according to a few levels of severity. This guideline has
been approved in year 2010 and valid until year 2014. In this new guidebook, the dengue patients are
no longer classified as DF and DHF, instead patients are divided into two simplified groups. They are
either severe or non-severe dengue patients. The non-severe dengue patients are further classified into
two subgroups: patients with warning signs and those without warning signs.
In the new WHO 2009 guidebook [2], the classification criteria for non-severe dengue without
warning signs are fever and any two of the following: nausea/vomiting, rash, aches and pain, a positive
tourniquet test, leucopoenia, and there may even be a combination of these warning signs. The warning
signs for non-severe dengue with warning signs are: abdominal pain or tenderness, persistent vomiting,
clinical fluid accumulation (pleural effusion/ascites), mucosal bleeding, lethargy, restlessness, liver
enlargement (>2 cm), and an increase in hematocrit (HCT) concurrent with a rapid decrease in platelet
count. Such patients with these warning signs require strict observation and medical intervention.
Severe dengue infections are characterized by significant plasma leakage, severe bleeding, and severe
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involvement of organs such as the liver. This causes liver enzymes such as aspartate aminotransferase
(AST), or the alanine aminotransferase (ALT) to be elevated with readings of ≥1000 units/L.
Laboratory diagnosis of dengue patients is used to detect the dengue virus. Currently, a definitive
diagnosis of dengue infection can be made only in the laboratory, either through virus isolation,
detection of viral antigen or ribonucleic acid (RNA) present in serum or other bodily fluid, detection of
antibodies present in serum, or a combination of these techniques [2,16]. At the early stage of
infection, virus isolation and the detection of nucleic acid or antigen is used to make a diagnosis of
dengue infection; however at the end of the acute phase of infection serological methods are more
suitable [2]. A number of commercially rapid test kits (or coated strips) have been developed by
various companies such as Korea’s Standard Diagnostics, Biorad and Panbio. These kits are able to
detect a combination of either antigen or antibodies [3].
Although rapid laboratory diagnosis is very important and highly desirable, of equal importance is
the recovery rate of the patient and the patient’s quality of life after recovery. To date, there is no
effective vaccine or antiviral drug for dengue [2]. Some of the dengue patients might recover
spontaneously while others face critical plasma loss that can lead to fatality [13]. Serology tests are not
able to diagnose the micro-vascular status (micro-vascular leakage or plasma leakage) of the patient
which is one of the major pathophysiological changes during dengue infection. Nevertheless the
fatality of dengue disease can be reduced by close monitoring of patients to detect the onset of plasma
leakage and administer prompt intravenous fluid replacement [17].
2.1. Biomedical Engineering Approaches
In order to overcome some of the difficulties in conventional dengue infection diagnostic methods,
a few biomedical engineering (BME) approaches were introduced by proposing non-invasive tools to
diagnose and classify the disease severity. These included techniques such as ultrasound imaging,
echocardiography, electrocardiography, plethysmography, laser Doppler velocimetry, bioelectrical
impedance, and intelligent clinical decision support systems. However, many of these papers reviewed
in the following sections were based on the WHO 1997 [13] dengue classification as the new WHO
2009 [2] classification was introduced in the year of 2010, after these papers have been published.
2.1.1. Ultrasound
The critical stage in dengue occurs when the capillary permeability increases which leads to plasma
leakage and therefore loss of plasma volume. The presence of pleural effusion and ascites are often
used to determine the degree of plasma leakage. These are clinically detectable through physical
examination techniques such as auscultatory percussion, and imaging techniques such as chest
radiography, and also abdominal and thoracic ultrasonic imaging. Accordingly, several studies have
used ultrasound as an aid for diagnosing dengue disease [18–20].
In the study by Srikiatkhachorn et al. [18] ultrasound has been employed to delineate the locations
and the timing of plasma leakage in DHF. In the study, one hundred fifty-eight suspected dengue cases
classified as DF, DHF, or other Febrile Illness (OFI) based on serology and evidence of plasma
leakage including hemoconcentration and pleural effusion, were investigated. Ultrasound examinations
of the abdomen and right thorax of patients were performed to detect ascites, thickened gall bladder
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wall, and pleural effusions. The results indicated that the timing of the plasma leakage was around the
time of defervescence. The Pleural effusion was the most common ultrasonographic sign of plasma
leakage while the thickening of the gallbladder wall and ascites were not associated as much in
determining the plasma leakage. Significantly, plasma leakage of 12 out of 17 DHF cases who did not
meet the WHO criteria for hemoconcentration signs was detected by ultrasound. The study concluded
that ultrasound imaging is a useful tool for detecting plasma leakage in dengue infection.
Another study by Venkata et al. [19] was conducted to determine the importance of the ultrasound
to clinical and laboratory profiles in diagnosing DF or DHF and to determine the usefulness of
ultrasound in predicting the severity of the disease. One hundred twenty-eight suspected dengue
patients (40 serologically negative for dengue fever and 88 serologically positive cases) were studied.
Results of 32 patients from the 88 cases who were examined on the second to third day and repeated
on fifth to seventh day showed that 100% had gall bladder wall thickening and pericholecystic fluid.
Follow-up ultrasound on the fifth to seventh day showed ascites in 53%, left pleural effusion in 22%,
and pericardial effusion in 28%. The results of the remaining 56 patients who were examined on the
fifth to seventh day of fever for the first time showed that 100% had gall bladder wall thickening, 96%
had ascites, 87.5% had right pleural effusion, and 66% had left pleural effusion. Contrary to the
previous study, this study reported that thickened gall bladder wall, pleural effusion, and ascites should
strongly favour the diagnosis of dengue fever.
In a separate work by Setiawan et al. [20], a study was conducted to examine the relationship
between the clinical severity of 148 DHF patients (73 grades I and II; 75 grades III and IV) and their
sonographic findings. Ultrasonography results revealed that the main features presented with grades I
and II DHF patients were hepatomegaly 49%, ascites 34%, gallbladder wall thickening 32%, and
pleural effusions 30%. On the other hand, the main features detected in DHF patients grades III and IV
groups were pleural effusions, ascites and gallbladder wall thickening 95%, pararenal and perirenal
fluid collections 77%, hepatomegaly 56%, and pancreatic gland enlargement 44%. The study
concluded that ultrasound may be useful for early prediction of the severity of DHF.
2.1.2. Echocardiography and Electrocardiography (ECG)
Echocardiography and electrocardiography (ECG) were utilized in several studies to assess cardiac
function of dengue patients [21–23].
Acute shock in severe DHF cases may occur in parallel with accumulation of fluid in serous body
spaces such as the pleural, peritoneal, and pericardial cavities [21]. Pelupessy et al. [21] investigated
the implementation of echocardiography in diagnosing dengue patients since echocardiography is a
very sensitive method for detecting any small quantity of pericardial effusion The study showed that,
although no signs of pericardial effusion could be determined on physical examination of DHF patients
associated with severe shock and through ECG and radiological procedures, echocardiogram results
were able to clearly show a small amount of fluid. Thus this technique is only recommended for the
application of acute shock dengue patients.
In 1998, Wali et al. [22] employed radionuclide ventriculography, echocardiography, and ECG to
assess cardiac function of 17 DHF and DSS patients. The radionuclide ventriculography results
revealed that, the mean left-ventricular ejection fraction was 41.69%. Seven patients had an ejection
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fraction of less than 40%. Global hypokinesia was detected in 70.59% of the patients. The
echocardiography results showed that the mean ejection fraction was 47.06%. The mean ejection
fraction of the 8 DSS patients was 39.63%. Five (67.5%) of those patients had an ejection fraction
below 40%. Radionuclide ventriculography and echocardiography showed no abnormalities after
3 weeks of follow up for five patients who had ST and T changes in their electrocardiogram.
The ejection fraction was more than 50% in these cases. Within 3 weeks, the Global hypokinesia also
improved and ECG changes reverted back to normal. The study concluded that acute reversible cardiac
insult may be noticed in DHF/DSS and could be responsible for hypotension/shock seen in some of
these patients. It was recommended that further studies are carried out to establish the pathogenic
mechanisms of cardiac dysfunction in patients with DHF and DSS.
In 1993, Yusoff et al. [23] performed echocardiograms and ECGs on 28 consecutive adult patients
with a clinical diagnosis of dengue infection. Twenty-three dengue patients were serologically
confirmed (22 DHF grades I and II; 1 DF). 87% of the serologically confirmed dengue patients had
abnormal ECGs and/or echocardiograms. Of these, 65% had abnormal ECGs that consisted of
conduction abnormalities, ST segment elevation, T wave inversion, and sinus bradycardia. Fifty-two
percent had abnormal echocardiograms which showed pericardial effusion, abnormal systolic and
diastolic functions, left ventricular dilatation, and tricuspid regurgitation. The authors declared that
ECG and echocardiographic abnormalities are common during the acute phase of DHF. They
recommended early detection of cardiac involvement as a way of identifying the more severe forms of
dengue so that appropriate treatment can be initiated as early as possible.
2.1.3. Strain Gauge Plethysmography
Liquid metal (Mercury-in-silicon elastomer tube) strain gauge plethysmography has been used in
various studies to assess the microvascular permeability in dengue patients [24,25]. Gamble et al. [24]
investigated the possible use of age-related changes in microvascular permeability as a health
indicator, and it was found that the value was highest in DSS young children. These findings indicated
that children significant factor in the susceptibility of children to DSS using strain gauge
plethysmography [24]. Both adults and children DSS patients were found to have higher vascular
permeability than the healthy control data, and the value was highest in the young children. These
findings indicated that children are more susceptible to develop hypovolaemic shock than adults in
DHF and other conditions characterized by increased microvascular permeability.
Bethell et al. [25], on the other hand, investigated whether the underlying pathophysiology of DSS
is distinct from the milder forms of the disease by assessing the microvascular permeability also using
strain gauge plethysmography. Three groups were investigated: children with DSS, DHF without
shock, and in healthy children. The mean coefficient based on the statistical analysis of microvascular
permeability for the patients with dengue was 50% higher than in healthy control patients. However,
there was no significant difference in the permeability between the two groups of patients with dengue,
which suggests the same underlying pathophysiology. This study also demonstrated that increased
microvascular leakage occurs in children with DHF, and is most pronounced in children with DSS.
However, the time taken to conduct the measurement was long (40 min average), and the procedure of
cuffing the patients may put the patients at risk by inducing more capillary leakage.
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2.1.4. Laser Doppler Velocimetry
Laser Doppler velocimetry has been widely used for assessment of various physiological
parameters, particularly involving blood perfusion and circulation [26–29]. The technique has also
been recently applied to DHF patients to evaluate the microcirculation changes due to plasma leakage
and increase of microvascular permeability [30]. The preliminary findings of this study indicated that
there were significant differences between basal laser Doppler flux in normal healthy subjects and
DHF patients. These results also implied that the technique has the potential as an indicator to
microcirculatory changes in DHF patients. The study has not; however been able to conclusively
differentiate the DHF severity stages using this technique.
2.1.5. Bioelectrical Impedance
Over the years, bioelectrical impedance analysis (BIA) has demonstrated its utility as a non-invasive
method for measurement and diagnosis in several medical applications. BIA evaluates the human body
composition such as mass distribution (i.e., body cell mass and extracellular mass), and water
compartments (i.e., intracellular water, extracellular water) by passing a small current through
it [31]. The majority of the impedance measurements use four electrodes to minimize electrode-skin
impedance effects. A small high-frequency current (50 kHz) is passed between two of the electrodes
while the voltage drop across the same area is then measured using the other pair of electrodes. The
ratio of the voltage drop to the current determines the resistance and reactance (Xc) of the body
segment being measured. This data can then estimate the extracellular water (ECW), intracellular
water (ICW), fat free mass (FFM), and fat mass through recognized equations [32].
BIA and bioelectrical impedance spectroscopy (BIS) have been described as a potentially reliable
method to assess clinically significant changes in extracellular and total body water in dengue
patients [33–37]. It could be a useful tool as a proxy for formal dilution methods to assess fluid shifts.
Pierson and Wang (1986) have also proposed that an elevation of the extracellular water
(ECW)/intracellular water (ICW) ratio in dengue patients, determined by dilution techniques, is a
sensitive but nonspecific marker for the presence of systemic disease, and total body impedance
measurements are especially useful in this determination.
In dengue infections several approaches were followed for utilizing the BIA technique.
The hydrational profile which reflects the distribution of body water between the intra and
extracellular space in dengue patients was investigated [38–44].
Studies conducted by Klassen et al. [42], Ibrahim et al. [38], and Mazariegos et al. [44] have shown
that BIA was sensitive in determining the hydrational profile in dengue patients. Klassen et al. [42]
studied the changes in hydrational status during the acute phase of classical dengue fever in 9 adult
patients. They studied the effects of the acute classical dengue fever on ECW, ICW, and total body
water (TBW) by comparing conventional dilution techniques with the outcome variables from whole
body impedance spectroscopy (BIS), extracellular fluid resistance (Recf), and intracellular fluid
resistance (Ricf) [42]. Two groups were investigated: a reference group comprised of 15 subjects
without acute or chronic illness and dengue patients. The dengue patients were investigated on
admission with febrile presentation (DI), at discharge after the defervescence of the fever cycle at
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about five days post-admission (DII), and seven days thereafter (DIII). The results revealed that the
total body water did not change during the course of the disease and was not different from that in
normal healthy subjects. However, the ratios of ECW/TBW and ECW/ICW reflected that body water
shifted from the intracellular to the extracellular compartment in patients from the acute phase to
convalescence. This ratio was also higher in convalescent dengue patients (DIII) compared to the
reference group. The results also showed an association between increasing ECW, from the acute
phase of the disease to convalescence and decreasing the Recf and the Recf/Ricf ratio. Moreover, the Recf
and Recf/Ricf values were higher in the acute phase (DI) of dengue fever compared to those of the
non-dengue subjects. The study concluded that relative expansion of ECW during the course of the
disease and in the convalescence stage as determined by measuring body impedance can be used to
monitor the dengue fever progression.
Fang et al. [45] reported a biosensor platform for dengue fever detection from patient serum. Their
sensor was based on a non-faradic process where an integrated sensor captures the dengue antibody
selectively from the sample. A thin film of sol-gel derived barium strontium titanate (BST) was coated
on the immunosensor surface, and then the surface was modified with an organic self-assembled
monolayer (SAM). In addition, pre-inactivated dengue virus was indirectly immobilized on the surface
to act as a sensing probe to capture the dengue antibody. Finally, the modified surface was based on a
finger shaped electrode where the output impedance/current will change in correlation with the
presence and concentrations of dengue antibody in the serum sample. The work was conducted at
frequency ranges of 0.1 Hz to 1 MHz.
Ibrahim et al. [46] monitored and modelled the hemoglobin (Hb) status in dengue patients using the
BIA parameters. The Hb status was used since it is directly related to the Hct status which can be used
to determine the degree of microvascular permeability in dengue patients. The BIA was employed to
construct a model for predicting Hb in dengue patients using the multivariate analysis technique.
Eighty-three (47 males and 36 females) serologically confirmed DF and DHF patients were studied
during their hospitalization. The data consisted of all the investigated parameters in BIA, patientsʼ
symptoms, and demographic data. Four predictors: reactance, gender, weight, and vomiting were
found to be the most significant parameters for predicting the Hb levels in dengue patients. The study
concluded that the single frequency bio-impedance technique and Multiple-linear-regression analysis
is insufficient to monitor Hb for dengue patients since this analysis only explains approximately 42%
of the Hb variation. This model has been enhanced by utilizing a non-linear artificial neural network
(ANN) and achieved 74% accuracy [47]. The graphical user interface for the model is shown in Figure 1.
The enhanced model is able to predict the Hb concentration which helps to determine the degree of
microvascular permeability in dengue patients based on the above mentioned data.
Additional enhancement of the model was achieved by employing the nonlinear autoregressive
moving average with exogenous input (NARMAX) approach [48]. Three different NARMAX model
order selection criteria, namely FPE, AIC, and Lipschitz were evaluated. The results gave 88.40%
prediction accuracy by using the Lipschitz number approach. The study concluded that the NARMAX
model yields better accuracy compared to the autoregressive moving average with exogenous input
(ARMAX) model which achieved 76.70% accuracy.
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Figure 1. Non-invasive haemoglobin modelling of dengue patients using bioelectric
impedance analysis and artificial neural networks.
2.1.6. Dengue Clinical Decision Support Systems
A physician’s knowledge would be sufficient to diagnose diseases that are directly related or
corroborate to the encyclopaedic aspects of medicine. However, the complexity of diseases such as
dengue and the many overlapping levels of its severity has created many difficulties for the physician
to predict the disease prognosis. Accordingly, there is a crucial need for a decision support system to
assist the health care provider in understanding the disease and to plan for its treatment. This is
especially true when providers with less training than a physician are caring for patients, a factor
crucially important in the developing world. In dengue, several approaches have been followed to
achieve this goal including the self-organized map, multilayer feed-forward neural networks
(MLFFNN), and adaptive neuro-fuzzy inference system (ANFIS) techniques.
Self-Organizing Map (SOM)
The self-organizing map (SOM) is an unsupervised neural network that is considered as one of the
most powerful aids for visualizing, analyzing, and understanding the complexity of high-dimensional
data. It receives a number of different multivariable input samples, discovers significant relationships
in these samples, and presents them into a two dimensional map. This map contains different data
clusters (prototypes), each of them consisting of samples that have similar features. Similarly,
relationships within the data and cluster structures can be visualized and interpreted. Therefore, the
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SOM can be considered as an exploratory data analysis tool for generating hypotheses on the
relationships among the data. The SOM has been widely used in medical applications [49–53]. Typical
SOM can be visualized by using the U-matrix and the component planes. The U-matrix visualizes the
distances between map units which is used to show the cluster structure of the map. Normally it is
colored and these colors represent the distance between map units [54]. Colors with high values in the
U-matrix indicate a cluster border while colors with low value indicate the clusters themselves. The
value of the color is presented in the color scale beside the U-matrix. On the other hand, the
component planes present values of all variable in each U-matrix map unit.
In dengue infections, the SOM was employed to identify the non-invasive significant prognosis
factors that can distinguish between dengue patients and healthy subjects and also distinguish between
the male and female patients [47]. The study presented a new approach to determine the significant
prognosis factors in dengue patients utilizing the SOM. This technique showed the significant factors
that can differentiate between dengue patients and the healthy subjects. Three hundred twenty-nine
samples (210 dengue patients and 119 healthy subjects) were used in the study. Each sample contained
35 predictors (17 BIA parameters, 18 symptoms/signs). Two SOMs were constructed as shown in
Figure 2. Each map contains the U-matrix (on the top left of the map) and the component planes that
represent the value of the variable in the U-matrix. The bottom left of each map shows the labels
which indicate the type of patient in each cluster of the U-matrix map (healthy subject (H) or dengue
patients (D)).The first map was constructed based on the BIA parameters data (variables) while the
second map utilized the symptoms and signs data (variables). By visualizing the U-matrix and
investigating the similarity between the clusters in the U-matrix and the component planes, the
correlations between the dengue patients and the prognosis factors form the symptoms and signs and
BIA parameters can be defined. The results revealed that, the significant BIA prognosis factors for
differentiating the dengue patients from the healthy subjects were reactance, ICW, ratio of ECW/ICW,
and ratio of the extracellular mass to body cell mass. On the other hand, abdominal epigastic pain,
petechiea rash, and bleeding tendency were the main signs and symptoms that were present in
dengue patients.
Due to the limitations of the WHO 1997 classification criteria that have been used to classify the
severity of dengue patients, Faisal et al. [55] employed clustering, the SOM’s technique to determine
new criteria that may help classify dengue patients based on disease severity. This technique aims to
apply the K-mean clustering technique to cluster the SOMʼs prototypes rather than clustering the data
directly to enhance the data clustering. Generally, the implementation of this approach is performed in
two stages: First, the SOM is trained to identify the prototypes of the dengue patients’ data, and
second, the K-mean clustering technique is implemented to cluster those prototypes. As a result, three
criteria were then defined to classify the level of risk in dengue patients. The results were validated by
comparing them to some other dengue researchers’ findings as well as the WHO criteria [2,13]. By
using this technique, important results were obtained: the new risk criteria classified 33% of the DF
patients as high risk dengue patients. Those patients might not be hospitalized according to the WHO
criteria since they were classified as DF patients. However, those patients were classified as high risk
by using the new criteria and thereby they might be at risk and face death if they are not closely
monitored to detect the onset of plasma leakage. Another significant result was that 65.5% and 57.7%
of the patients who were classified by WHO as DHF I and DHF II, respectively, were classified by the
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new criteria as low risk dengue patients. Those patients need not be hospitalized since they are classified
as low risk patients and therefore the savings on the cost of the hospital admissions can be substantial.
This result agrees with other researchers’ findings [14] and the recent WHO guidelines which indicates
there is a problem using the existing WHO classification due to the changes in the epidemiology of
dengue, and there is a high potential for the clinicians’ decision to be based the levels of severity for
classifying the patients [2].

(a)

(b)
Figure 2. (a) Visualization of the self organizing maps for the bioelectric impedance
analysis parameters; (b) Symptoms, and signs data. Reproduced with permission [47].
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Multilayer Feed-Forward Neural Networks (MLFFNN)
ANNs have been successfully applied to several problems in dengue disease. Ibrahim et al. [56]
employed the multi-layer perceptron (MLP) network trained via the back-propagation (BP) algorithm
to develop a prediction system for predicting the day of fever reduction in dengue patients due to the
fact that the progression of the DHF patient to DSS occurs following this day. Ninety percent
prediction accuracy was achieved by using this approach. The study concluded that since most of the
dengue patients were sick during or around the time of fever reduction, this ANN might be very
promising to assist clinicians in the early determination of prognosis and in prescribing the
management plan for their patients.
The network architecture designed by Ibrahim et al. [56] has been used to develop a GUI as shown
in Figure 3. The user interface is comprised of a few dialog boxes and radio buttons that request
patient information and input data for the prediction process. The patient information includes patient
identification and gender. The radio buttons are used to simplify user selection of the symptoms and
the signs presented by the dengue patients. The “predict the day of defervescence of fever” button
gives the estimated day of fever reduction. The entire system was compiled to function as a standalone
application that can be used in any computer environment.

Figure 3. Graphic interface screen for the prediction of day of defervescene of fever in
dengue patients.
Ibrahim et al. [39] introduced a novel approach to classify the risk in DHF patients by using the
BIA technique. A total of 184 (97 males and 87 females) serologically confirmed dengue patients
(DHF I–IV) were studied during their hospitalization. The relationship between gender and group with
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the biological electrical tissue conductivity BETC parameters was studied employing univariate
analysis of variance. The experimental results showed that BETC, specifically the reactance, was a
potentially useful tool in classifying the risk factor of DHF patients.
The work by Ibrahim et al. [39] has been extended to diagnose the risk in dengue infections using
an artificial neural network technique [57]. The study employed MLFFNN for classifying the risk
stages in dengue patients. In this study, the severity of risk in dengue disease was quantified using the
dengue patients’ blood data based on threshold values obtained from other researcher’s findings and
the WHO classification system [58]. Data comprises of 223 healthy subjects and 207 dengue patients
were arranged randomly into the training and testing in the ratio of 70:30. The ANN was trained via
the steepest descent back propagation with momentum algorithm method. The optimum network
architecture was determined by optimizing the training parameters. The optimization criteria was the
sum squared error (SSE) and total classification accuracy of the network. The total classification was
subjected to a 25% error tolerance. After the optimal ANN structure was determined, it was pruned using
a weight eliminating method to enhance the system performance. The overall classification accuracy was
96.27% with 95.88%, 96.83%, and 95.81% for high risk, low risk, and healthy groups, respectively.
Continuing research has taken the neural network architecture obtained from Ibrahim et al. [57].
and developed an automatic dengue risk classification. Using the Matlab software, a GUI has been
developed for use in real clinical applications as shown in Figure 4. The user interface is comprised of
a few dialog boxes and radio buttons that request patient information and input data for the diagnosis
process. The DIAGNOSE button is used to initiate MLFFNN calculation for each given input. The
system produces one of three outcomes: healthy, low risk, or high risk; and the result is displayed in
the bottom most dialog box.
The same technique and the same data were used by Faisal et al. [59] to develop a non-invasive
intelligent technique for diagnosing the risk stages in dengue patients using clinical manifestations
(signs and symptoms) and the BIA measurements. An accuracy of 70% with 0.121 sum squared error
was achieved by this model. The study concluded that such a screening system can aid physicians in
the diagnosis of the risk and the prognosis of dengue patients, but it will not be definitive.
Although the Multi-Layer Perceptron (MLP) trained via the back propagation (BP) algorithm has
demonstrated significant good performance in classification and prediction applications compared to
statistical analysis, it suffers from a slow convergence rate and often yields suboptimal
solutions [60,61]. To overcome this drawback, many researchers have employed the Levenberg-Marquardt
(LM) algorithm [62] or Scaled Conjugate Gradient (SCG) algorithm [36] for training the MLP since
these methods provide faster convergence and better estimation results. Those algorithms have been
successfully used in medical applications for classifying and diagnosing several diseases.
Faisal et al. [59] constructed the dengue patient diagnostic model using the LM and SCG
algorithms. Systematic procedures involving training, testing, and validation were followed to
construct the diagnostic model so that a higher performance of the diagnostic model can be achieved
and the robustness of overall diagnostic models can be maintained. Precise tuning of the internal
training algorithms’ parameters was performed to attain the optimal model. Three-layer network is
used. The activation function in hidden layer’s neurons is hyperbolic tangent sigmoid while in the
output layer’s neurons are sigmoid transfer function. The 5-fold Cross Validation (CV) technique is
implemented. The data are divided into five sets; each set contains 101 samples (45 high risk patients,
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56 low risk patients). Four sets (404 samples) were used for training and the remaining set was used
for testing. The training process was repeated for five times, at each time one of the sets was used as
testing set. The results for optimization of the MFNN trained via the Levenberg-Marquardt algorithm
showed that the optimal model achieved an average diagnostic accuracy of 70.7% with 73%
sensitivity, 74% specificity and a 0.02 average MSE. By implementing the scaled conjugate gradient
algorithm, the optimal diagnostic model achieved an average diagnostic accuracy of 75% with 0.01957
average MSE.

Figure 4. An Automatic dengue risk diagnostic system using artificial neural networks and
bioelectric impedance analysis techniques.
Adaptive Neuro-Fuzzy Inference System (ANFIS)
Even with the success of ANNs in a decision support system, the use of computerized decision
making systems in clinical medicine is rather difficult due to the uncertainty of naturally occurring
diseases. In such a situation, fuzzy set theory appears as an appropriate tool for a decision making
system since it deals with uncertainty by applying our knowledge and experience directly without any
explicit mathematical models. Fuzzy logic describes human thinking and reasoning in a mathematical
framework by using several rule bases (IF-THEN) that require a number of human experts to carefully
define the rules. Even though the fuzzy logic has been successfully implemented, there are some basic
aspects of it that are in need of better understanding. First, the need for a standard method for
transforming human knowledge or experience into the rule base and database of a fuzzy inference
system is noted. Second, there is a need for effective methods for tuning the membership
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functions [63]. Based on those needs, the Adaptive Neuro-Fuzzy Inference System (ANFIS) was
proposed to serve as a basis for constructing a set of fuzzy if-then rules with appropriate membership
functions to generate the stipulated input-output pairs [63].
Faisal et al. [64] utilized (ANFIS) to develop a dengue patient diagnostic model. The development
of the model was carried out in two steps: defining the initial ANFIS model architecture and training
of the defined model. Two approaches were followed to define the initial ANFIS model architecture.
In the first approach, the number of membership functions in the inputs and the output were
systematically varied and the effect of this variation in the model performance was investigated. In the
second approach, a subtractive clustering algorithm was assigned to determine the initial ANFIS model
by optimizing the number of membership functions and fuzzy rules. After the initial model structure
was defined, it was trained so that the differences between the output obtained from the model and
actual output are minimized. The hybrid learning algorithm was employed for this task. The results of
the first approach showed that the highest overall accuracy of 80.19% with 71% sensitivity and 86%
specificity was achieved. For the second approach, average diagnostic accuracy was 86.13% with
87.5% and 86.7 sensitivity and specificity, respectively.
The graphic user interface for the new ANFIS is shown in Figure 5. The user interface is comprised
of four parts: patient information such as patient's identification, symptoms and signs, the bioelectrical
impedance data, and the dengue patient risk diagnostic which determines the level of risk in
dengue patients.

Figure 5. Dengue patient diagnostic system based on Adaptive Neuro-Fuzzy Inference System.
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2.1.7. Dengue Fever Detection Using Microfluidic Lab-On-a-Disc (LOD) and
Lab-On-a-Chip (LOC) Platforms
Microfluidic devices have been proposed as a solution to overcome the many problems caused by
the conventional dengue testing systems such as the high cost, reagent consumption, long turnaround
time and complex procedures. Lab-on-a-disc (LOD) and lab-on-a-chip (LOC) are the most popular
microfluidic platforms that have been reported by many researchers as a portable diagnostic device for
dengue detection [65–67].
Ibrahim et al. [68] and Yusoff et al. [69] have discussed the fundamentals of the microfluidic
compact disc (CD) and its application as a platform for ELISA detection of dengue non-structural
glycoprotein 1 (NS-1), and Ibrahim et al. [68] designed and fabricated a microfluidic CD to
automatically perform an ELISA test for dengue detection.
On the other hand, lab-on-a-chip (LOC) has been proposed as a precise, rapid, and low cost
platform for dengue detection [70,71]. Lee et al. [70] reported an integrated microfluidic platform that
can detect the dengue virus by coating magnetic microbeads with antibody. A multi-way micropump
shown in Figure 6 is used for moving the serum sample, reagents and other buffers inside the
microfluidic net (channels and chambers). Lee et al. [72] claimed that the time required to perform one
test is 30 min, which is only 1/8th of the time required to detect dengue using a conventional testing
platform. Wenget al. [71] reported a new microfluidic LOC platform for dengue detection where a
suction method (instead of pumping) is used to move the liquid inside the device.
Polydimethylsiloxane (PDMS) has been used for the chip fabrication and the surfaces are
pre-functionalized to minimized protein adsorption. The dengue testing process can be finished within
30 min and the chip can stay stable for one month if it is stored at 4 °C.

Figure 6. The magnetic bead-based microfluidic chip measures 53 mm × 37 mm.
Reproduced with permission [72].
2.1.8. Dengue Virus Detection Using Paper-Based-Diagnostic Platform
The lab-on-paper, or paper-based diagnostic platform is a recently developed low cost method of
implementing point of care diagnosis. The paper-based devices are easy to use, low cost, disposable,
and can be used for a wide range of biomedical diagnosis [73–75].
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A medical patch developed by Martinez et al. [73] allows for the use of chromatography paper
as a low cost, low volume, and portable bioassay. The paper is patterned with test areas which are
doped with the required reagents, which change in color when it reacts with the intended analytes.
Matthews et al. [74] further enhanced the paper-based platform by developing an object identification
algorithm that is light enough for use on mobile phones. The application utilizes the built-in camera of
mobile phones for image capturing of the medical patch developed by Martinez et al. [73]. Once the
image is captured, a developed mobile application then performs the necessary image processing and
determines the disease state.
In a novel study conducted by Lo et al. [75], dengue virus is detected on a paper-based device for
the detection of dengue virus by first amplifying the nucleic acids via reverse transcription loop-mediated
isothermal amplification (RT-LAMP), then analysing the results using a colorimetric assay on paper. The
process of RT-LAMP is performed on Dengue serotype-2 ribonucleic acid (RNA) using conventional
microwell assay technique. Once the RT-LAMP process is completed, the DNA product is then
dropped on a waxed patterned 96-well paper where it is mixed with biotin-11-deoxyuridine, and then
conjugated with streptavidin horseradish peroxidase. The 96-well paper is then washed and scanned to
obtain the colorimetric results on a computer.The study concluded that the combination of RT-LAMP
andpaper-based colorimetric approach reduces the process time, while requiring very little sample
volume and is suitable for the point-of-care application.
2.2. Summary
The summaries of biomedical engineering techniques in dengue disease are listed in Tables 2–4.
Table 2 summarizes the biomedical engineering techniques of ultrasound, echocardiography and
electrocardiography (ECG), strain gauge plethysmography, laser Doppler velocimetry and bioelectrical
impedance in dengue disease. Table 3 summarizes the biomedical engineering techniques in dengue
clinical decision support systems. Table 4 summarizes the biomedical engineering techniques for dengue
fever detection using microfluidic lab-on-a-disc (LOD), lab-on-a-chip (LOC), and paper-based platforms.
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Table 2. Summary of biomedical engineering techniques of ultrasound, echocardiography and electrocardiography (ECG), strain gauge
plethysmography, laser Doppler velocimetry and bioelectrical impedance in dengue disease.
Authors

Year

Srikiatkhachorn
et al. [18]

2007

Studies
To delineate the locations and timing of
plasma leakage in DHF cases
Determination of the usefulness of
ultrasound in dengue disease severity
in patients
Examination of sonographs to identify
the relationship between the clinical
severity of DHF patients grades I/II and
grades III and IV.

Methods
Ultrasound

Venkata et al. [19]

2005

Setiawan et al. [20]

1989

Pelupessy et al. [21]

1989

Utilization of echocardiography to
diagnose dengue patients

Echocardiography and
electrocardiography (ECG)

Wali et al. [22]

1998

Assessment of cardiac function of DHF
and DSS patients

Radionuclide
ventriculography,
echocardiography, and ECG

Yusoff et al. [23]

1993

Investigation of echocardiograms and
ECGs in healthy and dengue patients

Echocardiography and
electrocardiography (ECG)

Gamble et al. [24]

2000

Investigation of age-related changes in
microvascular permeability in
dengue patients

Strain Gauge
Plethysmography

Children are more susceptible to develop hypovolaemic
shock than adults in DHF

2001

Assessment of microvascular to
differentiate children with DSS, DHF
without shock, and healthy children

Strain Gauge
Plethysmography

The microvascular permeability for patients with dengue
was 50% higher compared to healthy patients. However,
there was no significant difference in the permeability
between the DSS, DHF dengue patients

Bethell et al. [25]

Ultrasound

Findings/Results
The Pleural effusion was the most common
ultrasonographic sign of plasma leakage
in dengue infection
Thickened gall bladder wall, pleural effusion,
and ascites should strongly favor the
diagnosis of dengue fever
Pleural effusions, ascites and gallbladder wall
thickening, pararenal and perirenal fluid collections,
hepatomegaly, and pancreatic gland enlargement are
detected in in DHF patients grades III and IV
No signs of pericardial effusion could be determined on
physical examination of DHF patients associated with
severe shock. However echocardiogram results were able
to clearly show a small amount of fluid.
Acute reversible cardiac insult may be noticed
in DHF/DSS and could be responsible for
hypotension/shock seen in some patients.
ECG and echocardiographic abnormalities are common
during the acute phase of DHF which can be used as
early detection

Ultrasound
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Table 2. Cont.

Authors

Year

Hassan et al. [30]

2003

Klassen et al. [42]

2000

Fang et al. [45]

2010

Ibrahim et al. [46]

2004

Ibrahim et al. [46]

2008

Studies
Evaluation of microcirculation changes
due to plasma leakage and increase of
microvascular permeability in
DHF patients
Determining the hydrational profile in
dengue patients
Detection of dengue fever from
patient serum
Modeling of hemoglobin (Hb) status in
dengue patients using the
BIA parameters
Modeling of hemoglobin (Hb) status in
dengue patients using BIA parameters

Methods

Laser Doppler Velocimetry

Bioelectrical Impedance
Biosensor

Findings/Results
The technique can differentiate between normal healthy
subjects and DHF patients, but cannot clearly identify
the DHF severity stages
Body impedance can be used to monitor the dengue
fever progression.
The impedance changes in correlation with
concentrations of dengue antibody in serum samples

Multiple-linear-regression
analysis

Accuracy of 42% was achieved for modeling
the Hb variation

Artificial Neural Network
(ANN)

Accuracy of 74% was achieved for modeling
the Hb variation
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Table 3. Summary of biomedical engineering techniques in in dengue clinical decision support systems.

Authors

Year

Ibrahim et al. [39]

2005

Faisal et al. [47]

2008

Faisal et al. [55]

2010

Faisal et al. [59]

2010

Faisal et al. [59]

2010

Faisal et al. [64]

2012

Faisal et al. [64]

2012

Studies
Classification of dengue patients
based on disease severity
Distinguish between dengue
patients and healthy subjects using
self-organizing map
Determination of classification
criteria to classify the severity of
dengue disease
Classification of dengue patients
based on disease severity
Classification of dengue patients
based on disease severity
Classification of dengue patients
based on disease severity
Classification of dengue patients
based on disease severity

Methods
Multilayer Feed-Forward
Neural Networks
Self-organizing map

Self-organizing map
MFNN trained via the
Levenberg-Marquardt algorithm
MFNN trained via Scaled
Conjugate Gradient algorithm
Adaptive Neuro-Fuzzy
Inference System
Adaptive Neuro-Fuzzy
Inference System with subtractive
clustering algorithm

Findings/Results
Classification was achieved with accuracy
96.27%, sensitivity 95.88%, specificity
96.83%, and 25% error tolerance
4 significant bioelectrical impedance
parameters and 3 signs/symptoms were
defined to distinguish between the two groups.
Three criteria were defined to classify the
level of risk in dengue patients.
Classification was achieved with accuracy
70.7%, sensitivity 67%, specificity 74%
Classification was achieved with accuracy
75%, sensitivity 73%, specificity 74%
Classification was achieved with accuracy
80.19%, sensitivity 71%, specificity 86%
Classification was achieved with accuracy
86.13%, sensitivity 87.5%, specificity 86.7%
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Table 4. Summary of biomedical engineering techniques of microfluidic lab-on-a-disc (LOD), lab-on-a-chip (LOC), and paper-based
platforms in dengue disease.
Authors

Year

Ibrahim et al. [68]

2010

Yusoff et al. [69]

2009

Lee et al. [70]

2009

Weng et al. [71]

2011

Martinez et al. [73]

2007

Lo et al. [75]

2009

Matthews et al. [74]

2007

Studies
Investigation of the viability of the
microfluidic CD as a platform for ELISA
Development of microfluidic CD
as a platform for ELISA
Investigation of antibody coated
magnetic microbeads for speeding up the
ELISA process on the microfluidic CD
Investigation of suction based
pumping in microfluidic platform to
speed up the ELISA process
Investigation of patterned chromatography
paper for Dengue detection
Development of object identification algorithm
on mobile phones for analysing the paper based
patch developed by Martinez et al. [73]
Development of waxed patterned 96-well
paper to perform Dengue virus detection.

Methods

Findings/Results
Automated sequencing of ELISA for NS-1
Microfluidic Lab-on-a-Disc
detection can be accomplished on the CD
Demonstrated a CD design for automated
Microfluidic Lab-on-a-Disc
ELISA testing for Dengue NS-1.
Dengue testing time was reduced to
Microfluidic Lab-on-a-Chip 30 min (1/8th of the time compared to
with Microbeads
conventional 99-microwell method for
IgM and IgG ELISA)
Microfluidic Lab-on-a-Chip
Paper based
Paper based

Paper based

Dengue testing time is reduced to
30 min for IgG ELISA test
Paper based bioassay changes
color during detection.
Image captured by the mobile
application is processed and the
disease state is determined
The 96-well paper allows for
colorimetric detection that reduces the
process time, while requiring very little
sample volume and is suitable for
the point-of-care application.
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3. Malaria
Malaria is an infection that affects humans and some animals and is transmitted by infected female
Anopheles mosquitoes. Fever, headache, and in some severe cases patients progressing to coma or
death, are the common symptoms of this disease. Sub-Saharan Africa, Asia, and the Americas are the
areas where malaria is most prevalent [4]. In general, five types of the plasmodium have the capability
of causing human infection: P. falciparum, P. vivax, P. ovale, P. malariae, and P. Falciparum are
mainly found in Africa and some parts of Asia and South America [76]. P. falciparum is the common
cause of severe malaria cases that can lead to death. P. vivax is less fatal but can lead to serious anaemia
in children. Two hundred sixteen million cases of malaria were reported in 2011, where 81% of those
cases were found in Africa [4]. It is estimated that around 86% of these cases are children under 5 years
of age. The two common methods for diagnosis of malaria are light microscopy of blood and the rapid
diagnostic tests (RDTs) [77]. The main advantage of the light microscopy is the low cost in endemic
areas. However, the need for a highly trained operator and the lack of portability are the main
drawbacks. RDT testing kits are preferable in other areas but the cost of the RDT kits is high.
3.1. Biomedical Engineering Approaches
Several biomedical engineering approaches for malaria detection have been described including
microfluidic systems, image processing, and bioelectrical properties of blood. The following sections
review these approaches.
3.1.1. Image Processing
Many researchers have reported the auto-detection of malaria infection by utilizing image
processing techniques on microscopy images [78–85]. This work is based on images of cultured
malarial parasites that were grown under a controlled environment rather than in patients’ blood.
Rao [85] utilized the stained images of the P. falciparum to analyse its life cycle. At a later study by
Sio et al. [83], new software that automatically counts the malarial parasite has been reported. The
software focused on the counting of P. falciparum in images where the regular blood components and
other types of noise are not present. The algorithm applied is able to differentiate between infected and
uninfected red blood cells, and successfully count the parasites from peripheral blood specimens.
Dimension and colour of components were used for identification. Halim et al [80] performed
template matching techniques to detect red blood cells (RBC). Gray scale images were processed using
different image process techniques for parasite detection. The second developed method utilizes the
colour co-occurrence array that analyzes pixel colour index and the indicated colour of the surrounding
pixels. The various techniques produced results with accuracy of 80%–88% and a sensitivity of
92%–98%.
3.1.2. Microfluidics
The portability and the small volume of sample required to perform a test are the main advantages
of the microfluidic platforms [86]. These features, along with the low cost of the microfluidic platform
make it ideal to be used on site and in resource-limited areas.
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Different immunochromatographic methods (dipstick) of malaria infection detection have been
described [87,88]. These platforms are easy to use, portable, and can be used in the most challenging
environments. Most are based on the detection of malaria antigens from a patient’s blood sample.
The targeted antigen types include histidine-rich protein-2 (HRP-2), aldolase, and plasmodium lactate
dehydrogenase (pLDH). The developed methods have the ability to differentiate between the main
malaria types through the immunogenic differences in the proteins. Figure 7 shows an example of a
microfluidic platform (dipstick) that utilizes immunochromatographic lateral flow to detect malarial
proteins (antigen (Ag)) that are extracted from patient blood [89]. The disadvantage of the microfluidic
platforms is their accuracy which is less than that from gold standard microscopy techniques [90,91].
As the disease severity declines, the concentration of malarial antigens quickly decreases. Therefore,
these detection techniques are good for detection of recurrent infection and not for observing the
response of the patient to treatment.

Figure 7. Schematic of the lateral flow strip to diagnose Malaria. (top) Layout of the strip,
(middle) Flushing agent is added to help flush parasitized blood along the strip, and
(bottom) visible lines indicate presence of antigens in the parasitized blood. Reproduced
with permission [89].
Many platforms were proposed using the flow cytometry approaches for malaria detection have
been reported [92,93]. Saito-Ito et al. [93] presented a fast, high sensitivity, and low error diagnostic
platform that is capable of detecting the P. falciparum from a sample that contains erythrocytes and
stained parasites. The sensing principle was based on forward-angle light scattering from an argon
laser, and green fluorescence was utilized in this process. The author claimed that the required time to
perform a full test is 2–3 min including sample preparation. Jiménez-Díaz et al. [94] proposed a new
flow cytometric platform for malaria detection based on observing the differences of infected
erythrocytes stained auto-fluorescence and DNA content with that of healthy cells. The author claimed
that the proposed platform is rapid, simple to use, sensitive, and can accurately detect malarial pathogens.
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3.1.3. Paper-Based Microfluidic Cartridge
A method of paper-based microfluidics has been reported to prepare stained malaria parasites for
detection using traditional optical microscopy [95]. Horning et al. [95] presented a paper microfluidic
cartridge for automated staining of malaria parasites. The cartridge is similar to a dipstick, but replaces
the cellulose strip with paper. Blood is dropped onto a piece of dyeing hydrophilic paper which stains
the malaria parasites. The blood is then channeled by capillary forces through the paper into an
optically transparent slanted chamber which gradually get thinner. The slanted chamber produces a
thick smear near the paper, and a thin smear towards the end of the chamber. The cartridge can then be
examined using traditional optical microscopy. The authors claimed that the device is easy to use, fast,
low cost, has good optical properties, and is suitable for automated microscopy. A comparison with the
standard Giemsa smear technique has shown that the cartridge produces smears equal to that of a blood
smear as prepared on a microscope slide by an expert microscopist.
3.1.4. Microarray Chip
Recently, Jin et al. [96] proposed a microwell array chip that enables the analysis of single live
cells. The proposed system is capable to analyze more than 234,000 individual cells rapidly and efficiently.

Figure 8. Schematic diagram of the process for detection of malaria-infected erythrocytes
on a cell microarray chip. (a) Erythrocytes stained with a nuclei-specific fluorescent dye,
SYTO 59, for the staining of malaria nuclei dispersed on a cell microarray chip using a
pipette, which led to the formation of a monolayer of erythrocytes in the microchambers;
(b) Malaria-infected erythrocytes were detected using a microarray scanner with a
confocal fluorescence laser by monitoring fluorescence-positive erythrocytes; (c) The
target malaria-infected erythrocytes were analyzed quantitatively at the single-cell level.
Reproduced with permission [97]—open access.
Expanding on the work of Jin et al. [96], Yatsushiro et al. [97] reported a novel high-throughput
screening and analysis system for malaria infection using microarray chip with a laser scanner (Figure 8).
They utilized a polystyrene chip that contains 20,944 micro-chambers fabricated using molding
techniques. The author claimed that the system is 10 to 100 times more sensitive than the conventional
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light microscopy diagnosis method. This system requires 15 min to detect malaria parasites in erythrocytes
extracted from centrifuged blood.
3.1.5. Dielectrophoresis (DEP)
Dielectrophoresis (DEP) technology is utilized by many researchers for cell manipulating and
characterization [98]. DEP is the phenomenon that describes the motion of polarizable particles in a
non-uniform electric field. It allows for the recognition of differentiated populations of particles based
on their relative polarisibility. Separation between the living and dead cells is an example of
application of DEP; taking advantage of the unique electrical properties of each bioparticle [99].
Aceti et al. [100] found that the dielectric properties of erythrocytes infected with the malarial parasite
P. falciparum are different from normal erythrocytes. The electrical conductivity of the erythrocyte
membrane increases sharply when it is infected with Malaria parasites. This sharp increase was due to
changes in the composition, morphology and permeability of the erythrocyte membrane. Therefore,
Gascoyne et al. [101] utilized the DEP technique to separate the malarial infected cells from the
healthy cells by dielectrophoretic manipulation in a non-uniform electric field. Only a few microliters
of blood are required to detect malaria on the DEP platform.
3.1.6. Bioelectrical Properties
Lonappan et al. [102] studied the microwave characteristics of malaria and normal blood samples
using a cavity perturbation technique. This method has many advantages such as its simplicity, rapid
performance, reliable results and the small sample volume required to run the test. A significant
difference of the conductivity of malaria blood samples when compared with the normal healthy
samples was seen at frequencies of 2 to 3 GHz. This measurement is a new novel in vitro method of
diagnosing malaria at its onset using microwaves, and it will allow precautions to be taken early in the
disease course such as proper preventative drugs, which will improve disease prognosis [102].
Wilson et al. [103] developed an integrated system with dark-field reflection-mode and cross
polarization microscopy for the detection of hemozoin in fresh blood samples. Hemozoin is an
iron-containing pigment resulting from the breakdown of haemoglobin, found in the malaria parasite.
The presence of hemozoin results in a different light scattering effect when compared to healthy RBCs.
The result shows that incorporating both methods doubles the contrast when compared to the
individual techniques [103].
3.2. Summary
The summary of biomedical engineering techniques in malaria disease is listed in Table 5.
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Table 5. Summary of biomedical engineering techniques in malaria disease.

Authors
Halim et al. [80]

Year
2006

Studies
Development of template matching techniques
for detection of infection in blood smears.

Methods
Image processing

2007

malarial parasites in images of

of 80%–88% with a sensitivity of 92%–98%
The algorithm is able to differentiate between infected and uninfected red

Development of algorithm to automatically count
Sio et al. [83]

Findings/Results
Various image processing techniques presented yield a detection accuracy

Image processing

filtered blood samples

blood cells, and successfully counts the parasites in peripheral
blood specimens.

Development of a fast, high sensitivity, and low
Saito-Ito et al. [93]

2001

error diagnostic platform using light scattering in

Microfluidics—Cytometry

Allows for a full test to be performed in 2–3 min including sample preparation

flow cytometry
Development of flow cytometric method based
Jiménez‐Díaz et al. [94]

2005

on measuring autofluorescence and DNA content

Microfluidics—Cytometry

in stained infected erythrocytes
Development of dipstick-like paper microfluidic
Horning et al. [95]

2014

cartridge for automated staining of

The proposed platform is rapid, simple to use,
sensitive, and can accurately detect malarial pathogens.
The device produces results that are comparable to the

Microfluidics—Paper-based

malaria parasites

standard Giemsa smear technique, and has good optical properties to be
examined using traditional optical microscopy.
The microarray chip containing 20,944 chambers allows for 10 to 100 times

Yatsushiro et al. [97]

2010

Development of high-throughput screening and
analysis microarray chip

Microarray chip

higher sensitivity compared to conventional microscopy. It only takes
15 min to detect malaria parasites in erythrocytes extracted from
centrifuged blood.

Aceti et al. [100]

1990

Gascoyne et al. [101]

2002

Lonappan et al. [102]

2009

Investigation of dielectric properties of
erythrocytes infected with the malarial parasite
Investigation of identifying malarial infected
cells using dielectrophoretic
Investigation of microwave characteristics of
malaria infected and normal blood samples

Dielectrophoresis
Dielectrophoresis

2011

cross polarization microscopy in
malaria detection

when infected
Cell separation allows maria detection using only a few microliters
of blood
Using a cavity perturbation technique, significant difference of the

Bioelectrical

conductivity can be detected between malaria infected blood samples and
normal healthy samples at frequencies of 2 to 3 GHz.

Assessment of dark-field reflection-mode and
Wilson et al. [103]

Electrical conductivity of erythrocyte membrane increases sharply

Bioelectrical

Hemozoin (found in malaria parasite) has a light scattering effect that
doubles the contrast in cross polarized microscopy images
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4. Cholera
Cholera is an acute intestinal infection as a result of ingestion of food contaminated with the vibrio
cholerae bacteria. This infection has a short period of incubation from two to three days. If treatment is
not administered immediately, it causes an enterotoxin that leads to vomiting and excessive flowing
diarrhea that results in extensive dehydration. According to the WHO, the incidence of cholera has
been growing, with approximately 317,000 cases and 7500 deaths in 2010, demonstrating an increase
of 43% in the number of cases and 52% in the number of deaths compared to 2009 [6]. In areas where
cholera is endemic, the mortality rate has increased for children and pregnant women. Two types of
vaccines are available to protect against this disease, and it is easily treated by intravenous
rehydration [104].
Although standard culture methods can be employed for detection of v. Cholera, limitations
including low accuracy, the requirement of expertise and well equipped laboratory, and lengthy time
for diagnosis make it impractical in diagnosis of individual cases. Dark field microscopy and a dipstick
assay can be used to achieve a fast identification of v. Cholerae. These assays can yield results that
differ with the definitive culturing methods, therefore fluorescent monoclonal antibody and PCR-based
techniques have been developed to improve sensitivity and specificity of the assays [105].
4.1. Biomedical Engineering Approaches
A few biomedical approaches have been investigated to improve the detection of cholera toxin (CT).
4.1.1. Microfluidics
Bunyakul et al. [106] developed a microfluidic platform incorporating fluorescence and
electrochemical detection techniques for the detection of cholera toxin subunit B (CTB). The
microfluidic platform was fabricated using soft lithography on polydimethylsiloxane (PDMS). The
sample with CTB concentrations of up to 1000 ng/mL is injected into the platform towards a capture
zone withCTB-antibodies and ganglioside GM1 receptor immobilized onto magnetic beads. The beads
are then immobilized using an external magnet for washing and then transferred to a detection zone for
either fluorescence detection, or electrochemical detection. The implementation of the microfluidic
platform allows for limits of detection of 6.6 and 1.0 ng·mL−1 respectively for the fluorescence and
electrochemical techniques.
4.1.2. Impedance Techniques
Due to the low levels of lethal dose (LD) in humans [107], there is a high demand for detection
techniques capable to discriminate very low concentrations of the toxin. Labib et al. [108] developed
an immunosensor assay for the detection of CTB using a capacitive method. The sensor consists of a
gold electrode coated with monoclonal antibodies against CTB (anti-CTB) inserted into a capacitive
flow cell. Potential pulses of 50 mV at 50 Hz are transmitted through the capacitive flow cell, and the
transient currents evoked between the electrode and the capacitive flow cell are recorded and used to
calculate the capacitance of the liquid. The capacitance value recorded is found to decrease when CTB
binds with the anti-CTB coating on the electrode.
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4.2. Summary
The summary of biomedical engineering techniques in cholera disease is listed in Table 6.
Table 6. Summary of biomedical engineering techniques in cholera disease.
Authors

Year

Studies

Methods

Investigation of fluorescence and
Bunyakul et al. [106]

2009

electrochemical detection for

Limits of detection of 6.6 ng/mL and 1.0 ng/mL are
Microfluidics

2009

Development of capacitive

Capacitive

immunosensor assay for CTB

Impedance

detection

achievable respectively using the fluorescence and
electrochemical techniques.

CTB on microfluidic platform

Labib et al. [108]

Findings/Results

Measurement

When a 50 mV 50 Hz signal is applied to the
immunosensor (constructed from coated gold
electrode in a capactive flow cell), the capacitance of
the immunosensor decreases if CTB is present.

5. Schistosomiasis
Schistosomiasis is a type of parasitic infectious disease affecting at least 230 million individuals per
year in developing countries. It is caused by the trematode parasite worms, of the genus schistosoma.
The disease is classified into two major types; (a) intestinal schistosomiasis caused by S. guineensis,
S. mekongi, S. mansoni, S. japonicum, and S. intercalatum, and (b) urogenital schistosomiasis caused
by S. haematobium. Rapid multiplication and transmission of the schistosoma parasites lead to more
infected people each year. Furthermore, there is a high mortality rate of this disease, above 200,000
deaths per year in sub-Saharan Africa [5]. Shistosomiasis infection happens when parasites in larval
forms produced by snails in fresh water, penetrate the skin, often of the feet, that is exposed to infested
water. The larva then turns into mature schistosomes in the body. The adult female worms can produce
eggs in the blood vessels causing immune reactions and damaging tissues while others get out of the
body through urine or faeces.
In women, urogenital schistosomiasis can be considered as one of the risk factors for being infected
by human immunodeficiency virus (HIV). The body does not react to the worm but to the worm’s
eggs. Intestinal schistosomiasis can cause abdominal pain, diahrrea, enlargement of the liver, blood in
the stool, fluid accumulation in the peritoneal cavity, abdominal hypertension, and spleen enlargement.
Urogenital schistosomiasis, on the other hand, can cause haematuria, bladder and ureter fibrosis,
damage to kidney, and bladder cancer (as a possible late-stage complication).
Microscopic identification of eggs in specimens of stool or urine is the most efficient technique for
Schistosomiasis diagnosis. For detection of shistosomiamansoni and shistosomiajaponicum, only
microbiological methods such as the Kato-Katz technique can be applied. The severity of infection rate
is determined based on the number eggs per gram of stool sample [109]. However, this diagnostic test
is time-consuming, costly, and requires the skill of a trained parasitologist; all of which limit its utility
in the developing world.
5.1. Biomedical Engineering Approaches
The following sections demonstrate the most common biomedical engineering approaches for
diagnosis and prognosis of schistosomiasis including: bioelectrical impedance analysis (BIA),
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ultrasound, computerized tomography (CT), and magnetic resonance imaging (MRI). Imaging techniques
are considered as one of the most rapid, reliable, and accurate methods for detection of schistosomiasis.
5.1.1. Bioelectric Impedance Analysis (BIA)
BIA is an efficient method to assess the total body water (TBW) and its distribution between ECW
(Extracellular Water) and ICW (Intracellular Water), and it has been shown that BIA is sensitive to
TBW percentage alterations and the ECW to ICW ratio [110] that can provide an easy, inexpensive
analysis of body composition. In De Lorenzo et al.’s [110] study, body hydration, being defined as
total body water per kg of body weight, is considerably higher in patients with schistosomiasis than in
normal controls. De Lorenzo et al. [110] recruited schistosomiasis patients without clinical symptoms
such as no visible fluid retention, no cardiac or renal abnormalities from the underlying disease. BIA
was used to measure the amount of TBW and it was found that the percentage of body water is higher
in patients with schistosomiasis than in controls (62.9% ± 3.6% vs. 57.4% ± 4.3%, p < 0.0005).
Although, these patients’ anthropometric characteristic was similar with the control group, their
TBW% was higher. De Lorenzo et al. [110] discusses that various reasons may have partially
contributed the increased subclinical alterations in body hydration in patients with schistosomiasis. For
example, the subclinical alterations may be due to the arm fat area of schistosomiasis patients being
reduced to 20% lower than the control group [110]. However, it is observed that difference in TBW%
is small and may not be sufficient to allow a classification.
Hypoalbuminaemia is a cause of oedema. In the absence of fluid retention, albumin levels <1.5–2 g/dL
are required to have a clinically detectable increase of in ECW relative to TBW (ECW%) [111].
In De Lorenzo et al.’s [110] findings, one of the schistosomiasis patients experienced a 1.9 g/dL and
higher level with the absence of oedema. The findings suggest that albumin is vital in controlling body
water homeostatis in conditions of normal and subclinically altered body hydration. The findings
concluded that schistosomiasis subjects show an apparent subclinical increase in body hydration which
is related to the prediction of TBW from BIA.
5.1.2. Ultrasound Imaging of Hepatosplenic-Schistosomiasis
Ultrasound (US) is known to be one of the most effective methods for investigating liver and spleen
abnormalities caused by schistosomamansoni. Portal hypertension induced by the periportal fibrosis is
shown to be one of the main characteristics of the hepatosplenic form of schistosomiasis, it can be
demonstrated by ultrasound imaging through measurement of the diameter of the portal vein and its
main tributaries (splenic vein and superior mesenteric vein). Hepatosplenic schistosomiasis can induce
formation of collateral vessels in the gastrointestinal tract leading to acute bleeding or possibly death.
This phenomenon can be demonstrated by ultrasound imaging indicating an increased risk of bleeding
(Figure 9). Ultrasound can also be applied as a diagnostic tool in the assessment of treatment efficacy
and regression of fibrosis in schistosomiasis [112,113].
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Figure 9. Ultrasound B-scans of the abdomen showing changes caused by schistosomiasis.
White arrow: Central periportal fibrosis, red arrows: fibrosis on the periphery of the liver
in a patient diagnosed with advanced hepatosplenic schistosomiasis Reproduced with
permission [112].
5.1.3. Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI)
Diagnosis of hepatosplenic Schistomiasis can be obtained by observing characteristic changes of the
attenuation in the computerized tomography (CT) or signal intensity and enhancement pattern of the
magnetic resonance images (MRI) [112,114]. The CT and MRI findings are usually compared and are
in agreement with the ultrasound findings. In CT, low-density periportal zones are demonstrated as
periportal thickening when compared with echogenic layers in ultrasound images. These low-intensity
zones extend uniformly throughout the liver lobes and are enhanced after an intravenous injection of
contrast agents to become either homogenous with or denser than the surrounding hepatic tissue.
In MRI, on the other hand, periportal bands are demonstrated as areas of hyperintensity on
T1-weighted sequences and hyperintensity on T2-weighted sequences after the intravenous injection.
Studies of acute cases applying MRI demonstrated that regions of periportal fibrosis were hyperintense
on T2-weighted images in all patients (Figure 10). MRI has been known as a highly responsive
imaging technique for many diffused liver pathologies. Unlike ultrasound imaging, MRI is not a
dynamic method and also it is not dependent on the examiner.
In Japan, ultrasound, CT and MRI techniques and endoscopic examinations with biopsies have been
used to detect lesions related to schistosmiases japonica [114]. Portal hypertension is detected by CT,
Ultrsound and gastroscopic examination. The MRI imaging diagnoses were performed on chronic
lesions and/or sequelae of schistosemiasis and in well-equipped hospitals because of its high cost and
longer time of examination.
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Figure 10. MRI: Gamma-Gandy bodies (siderotic nodules) pointed by arrows labelled “i”
in the spleen of a patient diagnosed with hepatosplenicschistosomiasis. Arrow labelled “ii”
shows the portal vein. Reproduced with permission [112].
5.2. Summary
The summary of biomedical engineering techniques in schistosomiasis disease is listed in Table 7.
Table 7. Summary of the biomedical engineering techniques in schistosomiasis disease.
Authors
De Lorenzo
et al. [110]

Lambertucci
et al. [112]
Cheung
et al. [113]

Year

Studies

1997

Measurement of body
water using BIA in
schistosomiasis
patients

2008
1996

Detection of liver and
spleen abnormalities
caused by
shistosomamansoni
using ultrasound

Methods

Findings/Results

Bioelectric Impedance
Analysis (BIA)

Percentage of body water is higher in
patients with schistosomiasis than in
controls (62.9% ± 3.6% vs.
57.4% ± 4.3%, p < 0.0005).

Ultrasound imaging

Symptoms of schistosomiasis
(such as liver and spleen
abnormalities, formation of collateral
vessels in the gastrointestinal tract,
etc.) can be detected using
ultrasound imaging
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Table 7. Cont.

Authors

Lambertucci
et al. [112]

Ohmae
et al. [114]

Year

Studies

Methods

Findings/Results

2008

Application of CT and
MRI in detecting
schistomiasis
symptons

Computerized
Tomography (CT) and
Magnetic Resonance
Imaging (MRI)

In CT, low-density periportal zones
can be seen as periportal thickening
when compared with echogenic
layers in ultrasound images.
In MRI, periportal bands can be seen
as areas of hyperintensity on T1- and
T2-weighted sequences.

2003

Application of
Ultrasound, CT and
MRI in detecting
schistomiasis
symptons

Ultrasound,
Computerized
Tomography (CT),
Magnetic Resonance
Imaging (MRI)

Portal hypertension can be detected
by CT and US. MRI imaging is more
suitable for chronic lesions and/or
sequelae of schistosemiasis

6. Lymphatic Filariasis
Lymphatic Filariasis which is also known as elephantiasis, is responsible for more than 40 million
disfigured and infirm people, and intimidating more than 1.3 billion people in 72 countries [8].
The disease starts when an infected mosquito bites a human and transmits filarial parasites to the
human lymphatic vessels. Then, three types of filarial worms develop inside the infected body:
Wuchereria bancrofti, Brugia malayi and Brugia timori. These worms settle in the lymphatic system
for 6–8 years. During this incubation period, they produce large numbers of microlariae (larvae) that
interfere with the immune system. Although infection typically takes place during the childhood
period, painful disfiguration will occur later in life [8].
There are two main approaches for diagnosing lymphatic filariasis: microscopic examination and
serological tests. The first technique is to examine blood smears under the microscope to detect
microfilariaes. The blood must be collected at night; since the microfilariaes circulate in blood only at
night. Although this technique has a low sensitivity, it is still considered as an acceptable alternative
diagnostic method when antigen testing cannot be done [115]. On the other hand, serological tests are
based on the fact that filarial infection increases the concentrations of antifilarial IgG and IgE in the
blood. Thus, one can identify antifilarial immunoglobulin type G and E antibodies (IgG, IgE) or filarial
antigens using ELISA which leads to a higher sensitivity [115].
6.1. Biomedical Engineering Approaches
Few techniques have been investigated in order to overcome the limitations of lymphatic filariasis
diagnosis. The following sections show the available technologies of ultrasonography,
lymphoscintigraphy and immunochromatography.
6.1.1. Ultrasonography
Ultrasonography has been used to locate and study the movements of active adult filarial worms of
Wuchereria bancrofti in the scrotal region in men as a diagnostic tool for lymphatic filariasis; while
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only a few cases of adult filariae are observed by ultrasonography in women. This movement of
Wuchereria bancrofti is described as “filaria dance”; which is considered a sign of the presence of
Wuchereria bancrofti worms [116].
Dreyer et al. [117] used longitudinal ultrasound examination to investigate the microfilaria dance
sign in the scrotal lymphatic vessels. They found out that ultrasound is a beneficial tool to evaluate in a
direct and fast way the usefulness of antifilarial drugs. In another study done by Mand et al. [116],
they used a portable ultrasound unit, a 7.5 MHz linear transducer and a 3.5 MHz curved array
transducer to examine different positions in subjects’ bodies; in order to locate worm nests. The
findings showed that ultrasonography is suitable for diagnosis of Wuchereria bancrofti infection in
female patients as well as males.
6.1.2. Lymphoscintigraphy
Radioisotope imaging (scintigraphy) was demonstrated by Freedman et al. [118] as an effective
way to evaluate severity of the lymphatic filariasis; however, the primary diagnosis must be done by
non-imaging laboratory assays.
6.1.3. Immunochromatography
Weil et al. [119] described an immunochromatographic filarial antigen test using specific
monoclonal and polyclonal antibodies. The test is done by adding the serum onto a pink sample pad
which contains dried polyclonal antifilarial antibodies attached to colloidal gold. Then two drops of a
wash buffer are added to a separate wash pad. If the serum is infected, the labelled antibody and filarial
antigen move to the top of the card through a nitrocellulose strip resulting in a visible pink line. This
technique does not need professional operators; since its easy procedure can be done by individuals
without much training. Moreover, the results are accessible within only few minutes, making this test a
potentially fast diagnostic tool for lymphatic filariasis infection.
6.2. Summary
The summary of biomedical engineering techniques in lymphatic filariasis disease is listed in Table 8.
Table 8. Summary of biomedical engineering techniques in lymphatic filariasis disease.
Authors
Dreyer
et al. [117]

Mand
et al. [116]

Year

Studies

Methods

Application of longitudinal
1995

ultrasound in detecting lymphatic

The microfilaria dance sign in the
Ultrasonography

filariasis infection

2004

Findings/Results

scrotal lymphatic vessels can be
detected using ultrasonography.

Detection of lymphatic filariasis

Using ultrasonography, infestation of

infection using a 7.5 MHz linear

Wuchereria bancrofti can be detected

transducer and a 3.5 MHz curved
array transducer

Ultrasonography

by examining different positions in both
male and female subjects’ bodies
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Authors
Freedman
et al. [118]

Year

Studies

1994

imaging (scintigraphy) in detecting

Methods

Application of radioisotope

Radioisotope imaging allows the
Lymphoscintigraphy

lymphatic filariasis infection

et al. [119]

1997

using sample pad containing dried
polyclonal antifilarial antibodies
attached to colloidal gold

evaluation of the severity of the
lymphatic filariasis infection
The sample pad produced a visible

Development of an antigen test
Weil

Findings/Results

pink line when infected serum is
Immuno-chromatography

added to it. The technique does not
need professional and produces
results within a few minutes.

7. Ebola
The first recognition of Ebola virus infection occurred in 1976 in Zaire, Africa and the mortality
rate was 88% [7]. There are four types of Ebola virus including: Zaire, Sudan, Ivory Coast, and
Reston; the first two being responsible for the majority of hemorrhagic human fever resulting in the
high mortality rate [120]. Ebola can be confused with other diseases such as malaria, since the most
frequent symptoms include: fever, weakness, vomiting, diarrhea, sore throat and general aches [121].
The formal laboratory diagnostic technique is an ELISA, but this technique is not sensitive enough for all
different stages of disease and is not easily accessible in countries endemic for Ebola infection [122].
7.1. Biomedical Engineering Approaches
Although, ELISA is the routine test for Ebola, two techniques, RT-PCR (reverse transcriptase
polymerase chain reaction) and an optical biosensor have led to high sensitivity and specificity.
Optical Immunosensor
An optical immunosensor based on the photo immobilization technique to detect the two most
common types of Ebola virus, Zaire and Sudan was developed by Petrosova et al. [120]. The sensor
was fabricated by coating the tip of a fiber optic with a 200 nm layer of indium tin oxide (ITO), and
later with polypyrrole benzophenone. The tip is then irradiated with a 345 nm wavelength light at
intensity of 80 mW·cm−2 to excite the benzophenone radicals to bind to the Ebola virus antigen. The
fiber tip then goes through a process similar to a standard ELISA. The detection is then performed via
chemiluminescence measurements using a photo multiplier tube sensor. The results show that the
immunosensor is able to detect titers as low as 1:960,000 and 1:1,000,000 respectively for the Zaire
and Sudan strains.
7.2. Summary
The summary of the biomedical engineering technique in Ebola disease is listed in Table 9.
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Table 9. Summary of the biomedical engineering technique in Ebola disease.
Authors
Petrosova
et al [120]

Year

Studies

2007

Development of
immunosensor for
Zaire and Sudan trains
using fiber optic

Methods

Findings/Results

Optical
Immunosensor

The immunesensor is able to
detect Zaire and Sudan strains in
titers as low as 1:960,000 and
1:1,000,000 respectively

8. Leprosy
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. The cause of the disease was
identified in 1873 by G.H.A. Hansen and is also known as Hansen’s disease [123]. It remains a public
health problem and transmission continues, although prevalence has been reduced in the past half
century. Never the less leprosy remains as a leading infectious disease causing disabilities. At the
beginning of 2011, the global registered prevalence of leprosy from 130 territories stood around
192,000 cases, while during 2010 the number of newly detected cases was about 228,000 [9]. The primary
external sign of leprosy is skin lesions that if left untreated, can be progressive and cause permanent
damage to the limbs, eyes, nerves and skin. Thus early diagnosis and treatment is essential [124].
Mycobacterium leprae cannot be cultured in the laboratory, hence scientists are using innovative
techniques to measure the interaction of host cells with Mycobacterium leprae, however there still is
no primary method for prevention of leprosy nor a means of diagnostic and prognostic testing that is
practical in routine clinical care [125]. Problems with diagnosis of leprosy are related to its insidious
nature with sometimes conflicting immunological, clinical and pathological manifestations even
though there is minimal genetic variation among Mycobacterium leprae isolates worldwide.
An effective diagnosis method for all stages of the diseases is electroneuromyography (ENMG).
ENMG is a technique where the muscle nerve under study is stimulated with electric current. The
effectiveness is demonstrated by the presence of electroneuromyographic alterations among 98% of
leprosy confirmed patients, especially in the diagnosis of pure neural leprosy [126].
8.1. Biomedical Engineering Approaches
Although highly sensitive and specific diagnostic tests for Mycobacterium leprae have yet to be
established. Imaging techniques and biosensors, especially those based on employing DNA based
markers, are considered as strong promising leprosy diagnostic techniques.
Diagnostic Imaging
The incidence of bone lesions in leprosy is low, but the radiologic findings of chronic and acute
osteomyelitis that are similar to lesions of other granulomatous infectious agents are seen. Employing
imaging techniques various degrees of reabsorption of the body associated with leprosy involving feet
and hands with loss of disorganizing arthropathies and digits in small joints can be
visualized [126,127].
Magnetic resonance imaging (MRI) and ultrasonography (US) have been used as imaging
techniques for evaluation of pure neural leprosy. These imaging techniques employ specific markers
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and they have been used to assist in determining diagnosis and prognosis. US provides high resolution
images of the morphological alternations in peripheral nerves; however the value of this technique in
the diagnosis of peripheral neuropathy is poorly understood. Moreover, the application of MRI in
leprosy peripheral nerve involvement has been described in the literature, and there have been studies
of leprosy diagnosis using these techniques [127]. Goulart & Goulart [126] have shown that MRI and
Doppler ultrasonography have a sensitivity of 92% and 74%, respectively, to identify active reversal
reactions, based on the observation of the color flow signals. However, in case of tender neuropathy,
MRI may exclude nerve abscess, while US examination can be done more rapid and effective than
MRI imaging.
8.2. Summary
The summary of the biomedical engineering technique in leprosy disease is listed in Table 10.
Table 10. Summary of the biomedical engineering technique in leprosy disease.
Authors

Goulart &
Goulart [126]

Year

2008

Studies

Methods

Findings/Results

Applications of MRI
and US in detecting
symptoms of Leprosy

Magnetic
resonance imaging
(MRI) and
ultrasonography

MRI and ultrasonography have a sensitivity
of 92% and 74% respectively in identifying
active reversal reactions. Ultrasonography
examinations can be done more rapidly and
effectively than MRI imaging.

9. Leishmaniasis
Leishmaniasis is a neglected parasitic disease that is caused by the protozoan parasite of the
Leishmania genus and spread by the bite of female phlebotomine sand flies [12,128]. These flies inject
the infective stage of promastigote parasites into human hosts [10]. These are then phagocytized by
macrophages and transformed into amastigotes which will develop in the infected cells and cause skin
lesions that will take months or even years to heal [10] or which if left untreated, may be fatal [128].
Leishmaniasis is a public health problem that has being reported to have a 500% increasing incidence
in the most endemic areas in Africa, Asia, the Middle East, and the Mediterranean [10,11].
The established gold standards for Leishmaniasis detection involve the isolation of parasites either
microscopically or by culture [12]. Existing available diagnostic tests include histology, culture,
molecular techniques, Leishmanin skin test and serologic skin tests. Never the less those diagnostic
tests have their own limitations particularly due to false positives with Chagas disease and also to a
lesser extent to tuberculosis and leprosy [10,12].
9.1. Biomedical Engineering Approaches
To overcome the limitations of current diagnostic techniques, integrated electronic biosensors
systems that are suitable for field diagnosis are being developed [12].
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Impedance-Based Biosensor
Perinoto et al. [12] developed a nanostructured biosensor system to detect specific anti-leishmania
antibodies by measuring the capacitance of proteoliposomes integrated onto gold interdigitated
electrodes. These electrodes were functionalized by attaching antigenic proteins to the surface through
repeated immersing of the electrodes into a solution containing the antigenic proteins. Electrical
capacitance measurements of this structure containing immobilized proteoliposomes allow the
recognition of specific anti-Leishmania amazonensis antibodies at the concentration of 10−5 mg/mL [12].
This technique can be applied for the diagnosis of other protozoan and bacterial infectious diseases
such as the tuberculosis, malaria, filariasis, schistosomiasis, onchocerciasis and other neglected diseases.
9.2. Summary
The summary of the biomedical engineering technique in Leishmaniasis disease is listed in Table 11.
Table 11. Summary of the biomedical engineering technique in Leishmaniasis disease.
Authors

Perinoto
et al. [12]

Year

Studies

2010

Development of
nanostructured biosensor
system by integrating
proteoliposomes onto gold
interdigitated electrodes.

Methods

Findings/Results

Impedance-based
biosensor

Measuring the electrical capacitance of the
biosensor allow the recognition of specific
anti-Leishmania amazonensis antibodies
at concentration of 10−5 mg/mL

10. American Trypanosomiasis (Chagas Disease)
American trypanosomiasis, or Chagas disease is endemic in tropical areas and is caused by the
parasite Trypanosome cruzi. The parasite is transmitted by the triatomine family of bugs (commonly
known as “kissing bugs”) that act as reservoirs and vectors in endemic areas. As of 2002, 5–6 million
people were infected worldwide, with 25 million more at risk [129]. The Disease is typically found in
Latin America, however, due to population mobility, the disease has been increasingly detected in
North America, Europe and Western Pacific countries [129].
There are two phases of the disease: acute and chronic. The acute phase starts when the parasite
Trypanosome cruzi enters the body, and may last from 4 to 8 weeks. Local reaction at the point of
entry such as skin irritation occurs due to the bug bite or entry through the conjunctiva. Once
Trypanosome cruzi enters the body, the patient may experience common symptoms such as fever,
vomiting, diarrhoea, and anorexia. During this phase, a patient experiences acute myocarditis, where
an ECG may show signs of sinus tachycardia, first degree atrio-ventricular (A-V) block, low QRS
voltage, or primary T-wave changes. The chronic phase starts when the parasite can no longer be
detected in the blood, and symptoms of myocarditis and meningoencephalitis disappear. In this phase,
detection can only be done through serological tests such as IgG antibody detection. In the chronic
phase, 10%–30% of patients may suffer cardiac damage, while others may experience damage to the
cardiac conduction network and the autonomic nervous system [129,130].
For diagnosis of the acute phase of infection, parasites can be detected by direct parasitological
tests. Thin and thick blood smears allow microscopic observation of the parasite. [129,130]. In the
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chronic phase, only 50% of the patients may show positive results using parasitological tests.
Serological tests such as haemagglutination, indirect immuno fluorescence, and ELISA are more
applicable. Current approaches of detection have limitations in terms of consistency of results, and
requiring at least two techniques to be positive in order to properly diagnose Chagas infection.
However, as untreated Chagas may lead to damage to the cardiac conduction and autonomic nervous
system, biomedical engineering approaches have been investigated and developed for a more accurate
diagnosis of the disease.
10.1. Biomedical Engineering Approaches
In order to overcome the difficulties faced in Chagas diagnosis, biomedical engineers have
developed more accurate tools to help diagnose and identify the disease. This instrumentation consists
of biosensors that are based on electric impedance and current measurements.
Biosensors
A Chagas disease biosensor has been reported by Diniz et al. [131]. It had gold and platinum
electrodes that were coated with an oxide layer and recombinant antigens (cytoplasmic repetitive
antigen and flagellar repetitive antigen for Chagas), and dipped in patient’s serum. The study showed
that complex impedance increases much faster when the electrodes are dipped in Chagas positive
serum, compared to a slower increase in impedance when dipped in Chagas negative serum.
In a similar study by Ribone et al. [132], a biosensor utilizing gold electrodes was constructed.
Similar to the Chagas ELISA method, the electrode is covered with Trypanosome cruzi antigen that
reacts with patients’ anti-Trypanosome cruzi IgG. A classic enzyme label using horseradish peroxidase
conjugated with anti-human IgG was applied. However, instead of using the typical optical detection
method, a potential of less than 0.1 V was applied and electrode current was measured. An increase in
current indicates an increase in IgG antibody. In a separate study by Belluzo et al. [133], the same
biosensor was improvised with custom made chimeric receptors that react with the IgG antibody. The
biosensor was shown to achieve 100% specificity while attaining increased sensitivity with a detection
limit that is eight times lower compared to commercially available ELISA kits.
10.2. Summary
The summary of biomedical engineering techniques in Chagas disease is listed in Table 12.
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Table 12. Summary of biomedical engineering techniques in Chagas disease.
Authors

Year

Diniz
et al. [131]

2003

Ribone
et al. [132]

2006

Belluzo
et al. [133]

2011

Studies
Development of biosensor using
gold and platinum electrodes
coated with an oxide layer and
recombinant antigens
Development of biosensor using
gold electrodes covered with
Trypanosome cruzi antigen.
Enhancement of biosensor
by Ribone et al. [132] using
chimeric receptors

Methods

Biosensors

Biosensors

Biosensors

Findings/Results
Complex impedance of biosensor
increases much faster when dipped in
Chagas positive serum (as compared
to Chagas negative serum)
When applied to samples containing
anti-Trypanosome cruzi IgG, an
increase in current is measured.
The enhancement produced 100%
specificity and increased sensitivity.
The detection limit is eight times
lower than commercial ELISA kits

11. Conclusions and Outlook
This paper has reviewed the biomedical engineering approaches for diagnosing and monitoring
tropical diseases. Methods such as ultrasound, echocardiography and electrocardiography, strain gauge
plethysmography, laser Doppler and bioelectrical impedance and other techniques allow a noninvasive
approach to tropical disease diagnosis and management while overcoming the limitations of
conventional approaches. Clinical decision support systems based on self-organizing maps, multilayer
feed-forward neural networks and adaptive neuro-fuzzy inference systems assist clinicians to obtain a
more specific diagnosis of the disease type and stage, whereas lab-on-chip and micro/nanofluidics and
photonic approaches allow for a more sensitive and specific diagnosis at lower cost and a shorter
turnaround time. Although there has been much progress, there are still many opportunities to improve
these current biomedical engineering approaches as well as to develop new approaches for the
described and other tropical diseases.
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